NDx Clinical Research


Alzheimer's Clinical Trials

Advancing Alzheimer’s Research. Creating New Possibilities.


If you or a loved one has been diagnosed with Alzheimer’s disease, is experiencing changes in memory, or has concerns about future Alzheimer’s risk, you may be eligible for a clinical research study at NDx Clinical Research.

Alzheimer’s disease affects people differently—and research is evolving to address the disease at multiple stages. Our clinical research program offers opportunities ranging from studies for individuals who have not yet developed symptoms to trials for people living with Alzheimer’s disease and related symptoms.

Participation is always voluntary. Our research team will help you understand available studies and determine whether one may be an appropriate fit.

Currently Enrolling Alzheimer’s Studies


Our Alzheimer’s research program includes studies evaluating investigational approaches across different stages and symptoms of the disease.

MINDSET - Alzheimer’s Disease Study by Bristol Myers Squibb

For individuals living with Mild to Moderate Alzheimer’s disease


NDx is currently participating in a Bristol Myers Squibb clinical research study evaluating an investigational treatment for Alzheimer’s disease.



This study may be an option for individuals who have been diagnosed with Alzheimer’s disease and meet additional study-specific requirements.

LIGHTHOUSE - Alzheimer’s Disease & Gum Health Study

For individuals with Mild to Moderate Alzheimer’s disease and evidence of gum disease


Researchers are studying the potential relationship between certain bacteria associated with gum disease and Alzheimer’s disease.


The Lighthouse study is evaluating an investigational treatment in individuals with Alzheimer’s disease who test positive for P. gingivalis, a bacterium associated with periodontal disease.


Study-related testing is used to determine whether an individual meets the specific requirements for participation.

SPINOZA Trial - Pre-Clinical Alzheimer's Disease

An approach to early intervention 



The future of Alzheimer’s disease treatment may begin before memory loss ever develops. Through the SPINOZA Clinical Trial, NDx Clinical Research is exploring investigational treatment options aimed at intervening in Alzheimer’s disease before symptoms appear.


We are seeking adults 55 years and older with a family history of Alzheimer’s disease who are interested in learning more about early intervention. Our research team uses Alzheimer’s disease biomarkers and genetic testing to help determine eligibility for participation.


If Alzheimer’s disease runs in your family, we want to hear from you! Contact NDx Clinical Research today to speak with our team, learn more about the SPINOZA Trial, and find out whether you may qualify.

RESOLVE Study - Mild to Moderate Alzheimer's by Alpha Cognition

NDx Clinical Research is currently enrolling individuals diagnosed with mild to moderate Alzheimer's disease in a 12-week clinical trial evaluating the safety and tolerability of ZUNVEYL®, an FDA-approved medication for Alzheimer's disease.

 

 ZUNVEYL was developed as an alternative to traditional oral Alzheimer's treatments, such as Aricept (donepezil), with a formulation designed to reduce gastrointestinal side effects, including nausea, vomiting, and diarrhea.

 

 If you have previously tried donepezil and experienced gastrointestinal side effects, or are interested in exploring an alternative Alzheimer's treatment option, this study may be an opportunity for you!

Alzheimer's Registry - A Non-Investigational Oppurtunity

Interested in contributing to Alzheimer's research but unsure if an investigational clinical trial is right for you?  


NDx Clinical Research is currently enrolling individuals diagnosed with Alzheimer's disease in an observational research registry designed to better understand how Alzheimer's disease progresses and how patients respond to treatments used in routine clinical care. 


This registry is seeking individuals who are beginning a standard-of-care Alzheimer's treatment, including medications such as donepezil, memantine, or eligible amyloid-targeting therapies. Unlike traditional interventional clinical trials, this study does not require participants to take an investigational medication or change their prescribed treatment plan. Instead, researchers collect information about patients' health, cognitive function, daily activities, and treatment experiences over time. 


If you or someone you know has been diagnosed with Alzheimer's disease and is considering starting treatment, this may be an opportunity to contribute to meaningful research without participating in an investigational drug trial.

Not Sure Which Study Fits?


You do not need to know the name of a study or determine your own eligibility before contacting us.


Our research team can ask a few initial questions about your age, memory concerns, diagnosis, symptoms, medications, and medical history. From there, we can determine whether one of our currently enrolling studies may be worth exploring.


Even if one study isn't a match, another research opportunity may be available.

What Does Participation Involve?


Every clinical trial is different. Before you decide whether to participate, our research team will explain the study in detail, including its purpose, requirements, potential risks and benefits, and expected time commitment.


Participation typically begins with an initial conversation with our research team. If a study appears to be a potential match, you may be invited to our research center to learn more.


Before any study-specific procedures are performed, you will review an informed consent form and have an opportunity to ask questions.


Additional screening may include medical history, memory or cognitive assessments, physical examinations, laboratory testing, imaging, or other evaluations depending on the study.


Participation is completely voluntary.

Who May Qualify?


Our Alzheimer’s research opportunities change throughout the year and may include studies for:

  • Adults without noticeable memory problems who may be at increased risk for Alzheimer’s disease
  • Individuals experiencing memory or thinking changes
  • Individuals diagnosed with Mild Cognitive Impairment (MCI)
  • Individuals diagnosed with mild, moderate, or more advanced Alzheimer’s disease
  • Individuals experiencing behavioral symptoms associated with Alzheimer’s disease, including hallucinations, delusions, agitation, or other changes
  • Care partners and family members supporting someone living with Alzheimer’s disease


You do not need to know your exact diagnosis or which study may be appropriate before contacting us. Our research team can help determine whether one of our current studies may be a potential fit.

Frequently Asked Questions


  • Do I need an Alzheimer’s diagnosis to participate?

    Not necessarily. Eligibility depends on the individual study.


    Some of our studies are designed for people who have been diagnosed with Alzheimer’s disease, while others may be appropriate for individuals experiencing memory changes or even people who have no noticeable symptoms.

  • Will I receive the investigational medication?

    Not necessarily. Some clinical trials compare an investigational treatment with a placebo or another treatment. The research team will explain the design of a specific study before you decide whether to participate.

  • Is there a cost to participate?

    Study-related procedures and investigational treatments are available at no cost. Insurance is not required nor collected by our study staff. 

  • Will I be compensated?

    Compensation for time and travel may be available depending on the study. The amount and requirements vary by clinical trial and will be reviewed with you before participation.

  • Does a caregiver need to participate?

    Many Alzheimer’s clinical trials require a study partner or caregiver who knows the participant well and can attend certain study visits.


    Requirements vary by study, and our team can explain what is expected during your initial conversation.

  • Can I change my mind after joining?

    Yes. Clinical trial participation is voluntary. You may decide not to participate or withdraw from a study at any time.

Take the First Step


You Don't Have to Know Where to Start.

You don't have to determine whether you qualify on your own.


If you or someone you care for has Alzheimer’s disease, has noticed changes in memory, is experiencing hallucinations or delusions associated with Alzheimer’s disease, or is interested in research before symptoms develop, our team can help you explore current opportunities.